In the last 12 months, insiders at ORAMED PHARMACEUTICALS INC. ($ORMP) filed 83 transactions with the SEC: 0 open-market purchases totaling $0 and 0 sales totaling $0. Net insider sentiment: neutral.
ORAMED PHARMACEUTICALS INC. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Kidron Miriam (Chief Scientific Officer) — 14 transactions totaling $1,440,128
- KIDRON NADAV (President and CEO) — 14 transactions totaling $148,348
- Silberman David (Chief Financial Officer) — 1 transaction totaling $0
- Reznick Yehuda (Director) — 6 transactions totaling $0
- Shapiro Benjamin (Director) — 6 transactions totaling $0
View all SEC Filings for ORAMED PHARMACEUTICALS INC. (ORMP).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 30, 2026 | KIDRON NADAV | President and CEO | F | Common Stock | 44818 | $3.31 | 3,548,243.0000 | 42,418,644 | 1.25% | 0.11% |
| March 30, 2026 | Kidron Miriam | Chief Scientific Officer | F | Common Stock | 435084 | $3.31 | 1,133,138.0000 | 42,418,644 | 27.74% | 1.03% |
| March 17, 2026 | Hexter Joshua | COO & CBO | A | Common Stock | 95889 | $0.00 | 1,160,384.0000 | 42,774,504 | 9.01% | 0.22% |
| March 17, 2026 | Kidron Miriam | Chief Scientific Officer | A | Common Stock | 119558 | $0.00 | 1,568,222.0000 | 42,774,504 | 8.25% | 0.28% |
| March 17, 2026 | Gabay Avraham | Chief Financial Officer | A | Common Stock | 95889 | $0.00 | 745,145.0000 | 42,774,504 | 14.77% | 0.22% |
| March 17, 2026 | KIDRON NADAV | President and CEO | A | Common Stock | 167005 | $0.00 | 3,422,243.0000 | 42,774,504 | 5.13% | 0.39% |
| March 12, 2026 | KIDRON NADAV | President and CEO | G | Common Stock | 100000 | $0.00 | 3,255,238.0000 | 42,774,504 | 2.98% | 0.23% |
| Jan. 22, 2026 | Kidron Miriam | Chief Scientific Officer | M | Performance Stock Units | 19000 | $0.00 | 0.0000 | 42,774,504 | 100.00% | 0.04% |
| Jan. 22, 2026 | Gabay Avraham | Chief Financial Officer | M | Performance Stock Units | 19000 | $0.00 | 0.0000 | 42,774,504 | 100.00% | 0.04% |
| Jan. 22, 2026 | KIDRON NADAV | President and CEO | M | Common Stock | 109000 | $0.00 | 3,355,238.0000 | 42,774,504 | 3.36% | 0.25% |
| Jan. 22, 2026 | KIDRON NADAV | President and CEO | M | Performance Stock Units | 109000 | $0.00 | 0.0000 | 42,774,504 | 100.00% | 0.25% |
| Jan. 22, 2026 | Gabay Avraham | Chief Financial Officer | M | Common Stock | 19000 | $0.00 | 649,256.0000 | 42,774,504 | 3.01% | 0.04% |
| Jan. 22, 2026 | Hexter Joshua | COO & CBO | M | Performance Stock Units | 19000 | $0.00 | 0.0000 | 42,774,504 | 100.00% | 0.04% |
| Jan. 22, 2026 | Hexter Joshua | COO & CBO | M | Common Stock | 19000 | $0.00 | 1,064,495.0000 | 42,774,504 | 1.82% | 0.04% |
| Jan. 22, 2026 | Kidron Miriam | Chief Scientific Officer | M | Common Stock | 19000 | $0.00 | 1,448,664.0000 | 42,774,504 | 1.33% | 0.04% |
| Jan. 14, 2026 | Kidron Miriam | Chief Scientific Officer | G | Common Stock | 86166 | $0.00 | 1,343,498.0000 | 42,774,504 | 6.03% | 0.20% |
| Dec. 31, 2025 | Kidron Miriam | Chief Scientific Officer | A | Common Stock | 115000 | $0.00 | 1,429,664.0000 | 42,774,504 | 8.75% | 0.27% |
| Dec. 31, 2025 | Reznick Yehuda | Director | A | Common Stock | 30000 | $0.00 | 98,930.0000 | 42,774,504 | 43.52% | 0.07% |
| Dec. 31, 2025 | Reznick Yehuda | Director | A | Common Stock | 6250 | $0.00 | 105,180.0000 | 42,774,504 | 6.32% | 0.01% |
| Dec. 31, 2025 | KIDRON NADAV | President and CEO | A | Common Stock | 232640 | $0.00 | 3,045,238.0000 | 42,774,504 | 8.27% | 0.54% |
| Dec. 31, 2025 | KIDRON NADAV | President and CEO | A | Common Stock | 327000 | $0.00 | 3,372,238.0000 | 42,774,504 | 10.74% | 0.76% |
| Dec. 31, 2025 | KIDRON NADAV | President and CEO | A | Performance Stock Units | 109000 | $0.00 | 109,000.0000 | 42,774,504 | 9999.99% | 0.25% |
| Dec. 31, 2025 | Mayer Arie | Director | A | Common Stock | 4900 | $0.00 | 168,009.0000 | 42,774,504 | 3.00% | 0.01% |
| Dec. 31, 2025 | Mayer Arie | Director | A | Common Stock | 30000 | $0.00 | 163,109.0000 | 42,774,504 | 22.54% | 0.07% |
| Dec. 31, 2025 | Shapiro Benjamin | Director | A | Common Stock | 3500 | $0.00 | 2,023,220.0000 | 42,774,504 | 0.17% | 0.01% |
| Dec. 31, 2025 | Shapiro Benjamin | Director | A | Common Stock | 30000 | $0.00 | 2,019,720.0000 | 42,774,504 | 1.51% | 0.07% |
| Dec. 31, 2025 | Hexter Joshua | COO & CBO | A | Performance Stock Units | 19000 | $0.00 | 19,000.0000 | 42,774,504 | 9999.99% | 0.04% |
| Dec. 31, 2025 | Hexter Joshua | COO & CBO | A | Common Stock | 115000 | $0.00 | 1,045,495.0000 | 42,774,504 | 12.36% | 0.27% |
| Dec. 31, 2025 | Hexter Joshua | COO & CBO | A | Common Stock | 97328 | $0.00 | 930,495.0000 | 42,774,504 | 11.68% | 0.23% |
| Dec. 31, 2025 | Kidron Miriam | Chief Scientific Officer | A | Performance Stock Units | 19000 | $0.00 | 19,000.0000 | 42,774,504 | 9999.99% | 0.04% |
| Dec. 31, 2025 | Kidron Miriam | Chief Scientific Officer | A | Common Stock | 121331 | $0.00 | 1,314,664.0000 | 42,774,504 | 10.17% | 0.28% |
| Dec. 31, 2025 | Aghion Daniel | Director | A | Common Stock | 30000 | $0.00 | 107,191.0000 | 42,774,504 | 38.86% | 0.07% |
| Dec. 31, 2025 | Gabay Avraham | Chief Financial Officer | A | Performance Stock Units | 19000 | $0.00 | 19,000.0000 | 42,774,504 | 9999.99% | 0.04% |
| Dec. 31, 2025 | Gabay Avraham | Chief Financial Officer | A | Common Stock | 115000 | $0.00 | 630,256.0000 | 42,774,504 | 22.32% | 0.27% |
| Dec. 31, 2025 | Gabay Avraham | Chief Financial Officer | A | Common Stock | 81216 | $0.00 | 515,256.0000 | 42,774,504 | 18.71% | 0.19% |
| Dec. 31, 2025 | Aghion Daniel | Director | A | Common Stock | 6250 | $0.00 | 113,441.0000 | 42,774,504 | 5.83% | 0.01% |
| June 5, 2025 | Sank Leonard | Director | A | Common Stock | 6510 | $0.00 | 134,531.0000 | 41,228,782 | 5.09% | 0.02% |
| June 5, 2025 | Sank Leonard | Director | A | Common Stock | 30000 | $0.00 | 128,021.0000 | 41,228,782 | 30.61% | 0.07% |
| June 5, 2025 | Reznick Yehuda | Director | A | Common Stock | 8370 | $0.00 | 68,930.0000 | 41,228,782 | 13.82% | 0.02% |
| June 5, 2025 | Reznick Yehuda | Director | A | Common Stock | 30000 | $0.00 | 60,560.0000 | 41,228,782 | 98.17% | 0.07% |
| June 5, 2025 | Aghion Daniel | Director | A | Common Stock | 30000 | $0.00 | 68,820.0000 | 41,228,782 | 77.28% | 0.07% |
| June 5, 2025 | Aghion Daniel | Director | A | Common Stock | 8371 | $0.00 | 77,191.0000 | 41,228,782 | 12.16% | 0.02% |
| June 5, 2025 | Mayer Arie | Director | A | Common Stock | 30000 | $0.00 | 126,134.0000 | 41,228,782 | 31.21% | 0.07% |
| June 5, 2025 | Mayer Arie | Director | A | Common Stock | 6975 | $0.00 | 133,109.0000 | 41,228,782 | 5.53% | 0.02% |
| June 5, 2025 | Shapiro Benjamin | Director | A | Common Stock | 4650 | $0.00 | 1,989,720.0000 | 41,228,782 | 0.23% | 0.01% |
| June 5, 2025 | Shapiro Benjamin | Director | A | Common Stock | 30000 | $0.00 | 1,985,070.0000 | 41,228,782 | 1.53% | 0.07% |
| Feb. 11, 2025 | Gabay Avraham | Chief Financial Officer | A | Common Stock | 42000 | $0.00 | 434,040.0000 | 40,828,380 | 10.71% | 0.10% |
| Feb. 11, 2025 | Kidron Miriam | Chief Scientific Officer | A | Common Stock | 74000 | $0.00 | 1,074,666.0000 | 40,828,380 | 7.40% | 0.18% |
| Feb. 11, 2025 | Kidron Miriam | Chief Scientific Officer | A | Common Stock | 52000 | $0.00 | 1,126,666.0000 | 40,828,380 | 4.84% | 0.13% |
| Feb. 11, 2025 | Kidron Miriam | Chief Scientific Officer | A | Common Stock | 66667 | $0.00 | 1,193,333.0000 | 40,828,380 | 5.92% | 0.16% |
| Feb. 11, 2025 | Hexter Joshua | COO & CBO | A | Common Stock | 45000 | $0.00 | 751,333.0000 | 40,828,380 | 6.37% | 0.11% |
| Feb. 11, 2025 | Hexter Joshua | COO & CBO | A | Common Stock | 48500 | $0.00 | 799,833.0000 | 40,828,380 | 6.46% | 0.12% |
| Feb. 11, 2025 | Hexter Joshua | COO & CBO | A | Common Stock | 33334 | $0.00 | 833,167.0000 | 40,828,380 | 4.17% | 0.08% |
| Feb. 11, 2025 | KIDRON NADAV | President and CEO | A | Common Stock | 141000 | $0.00 | 2,526,598.0000 | 40,828,380 | 5.91% | 0.35% |
| Feb. 11, 2025 | KIDRON NADAV | President and CEO | A | Common Stock | 186000 | $0.00 | 2,712,598.0000 | 40,828,380 | 7.36% | 0.46% |
| Feb. 11, 2025 | KIDRON NADAV | President and CEO | A | Common Stock | 100000 | $0.00 | 2,812,598.0000 | 40,828,380 | 3.69% | 0.24% |
| Feb. 11, 2025 | Gabay Avraham | Chief Financial Officer | A | Common Stock | 34000 | $0.00 | 392,040.0000 | 40,828,380 | 9.50% | 0.08% |
| Jan. 2, 2025 | KIDRON NADAV | President and CEO | A | Common Stock | 433500 | $0.00 | 2,385,598.0000 | 40,828,380 | 22.21% | 1.06% |
| Jan. 2, 2025 | Gabay Avraham | Chief Financial Officer | A | Common Stock | 188000 | $0.00 | 358,040.0000 | 40,828,380 | 110.56% | 0.46% |
| Jan. 2, 2025 | Hexter Joshua | COO & CBO | A | Common Stock | 194500 | $0.00 | 706,333.0000 | 40,828,380 | 38.00% | 0.48% |
| Jan. 2, 2025 | Kidron Miriam | Chief Scientific Officer | A | Common Stock | 207000 | $0.00 | 1,000,666.0000 | 40,828,380 | 26.08% | 0.51% |
| Nov. 7, 2024 | KIDRON NADAV | President and CEO | A | Common Stock | 45000 | $0.00 | 1,952,098.0000 | 40,896,845 | 2.36% | 0.11% |
| Nov. 7, 2024 | Hexter Joshua | COO & CBO | A | Common Stock | 30000 | $0.00 | 511,833.0000 | 40,896,845 | 6.23% | 0.07% |
| Nov. 7, 2024 | Kidron Miriam | Chief Scientific Officer | A | Common Stock | 30000 | $0.00 | 793,666.0000 | 40,896,845 | 3.93% | 0.07% |
| Nov. 7, 2024 | Gabay Avraham | Chief Financial Officer | A | Common Stock | 30000 | $0.00 | 170,040.0000 | 40,896,845 | 21.42% | 0.07% |
| June 21, 2024 | Gabay Avraham | Chief Financial Officer | A | Common Stock | 140040 | $0.00 | 0.0000 | 41,564,007 | 0.00% | 0.34% |
| June 6, 2024 | Reznick Yehuda | Director | A | Common Stock | 760 | $0.00 | 30,560.0000 | 41,564,007 | 2.55% | 0.00% |
| April 17, 2024 | Reznick Yehuda | Director | A | Common Stock | 29800 | $0.00 | 29,800.0000 | 41,564,007 | 9999.99% | 0.07% |
| Jan. 30, 2024 | Aghion Daniel | Director | A | Common Stock | 3750 | $0.00 | 38,820.0000 | 40,566,901 | 10.69% | 0.01% |
| Jan. 4, 2024 | KIDRON NADAV | President and CEO | A | Common Stock | 329000 | $0.00 | 1,907,098.0000 | 40,566,901 | 20.85% | 0.81% |
| Jan. 4, 2024 | Shapiro Benjamin | Director | A | Common Stock | 5070 | $0.00 | 1,955,070.0000 | 40,566,901 | 0.26% | 0.01% |
| Jan. 4, 2024 | Kidron Miriam | Chief Scientific Officer | A | Common Stock | 295500 | $0.00 | 763,666.0000 | 40,566,901 | 63.12% | 0.73% |
| Jan. 4, 2024 | Shapiro Benjamin | Director | A | Common Stock | 30000 | $0.00 | 1,950,000.0000 | 40,566,901 | 1.56% | 0.07% |
| Jan. 4, 2024 | Aghion Daniel | Director | A | Common Stock | 5070 | $0.00 | 35,070.0000 | 40,566,901 | 16.90% | 0.01% |
| Jan. 4, 2024 | Aghion Daniel | Director | A | Common Stock | 30000 | $0.00 | 30,000.0000 | 40,566,901 | 9999.99% | 0.07% |
| Jan. 4, 2024 | Mayer Arie | Director | A | Common Stock | 9325 | $0.00 | 96,134.0000 | 40,566,901 | 10.74% | 0.02% |
| Jan. 4, 2024 | Mayer Arie | Director | A | Common Stock | 30000 | $0.00 | 86,809.0000 | 40,566,901 | 52.81% | 0.07% |
| Jan. 4, 2024 | Rozov Yadin | Director | A | Common Stock | 8820 | $0.00 | 155,320.0000 | 40,566,901 | 6.02% | 0.02% |
| Jan. 4, 2024 | Rozov Yadin | Director | A | Common Stock | 30000 | $0.00 | 146,500.0000 | 40,566,901 | 25.75% | 0.07% |
| Jan. 4, 2024 | Sank Leonard | Director | A | Common Stock | 9325 | $0.00 | 98,021.0000 | 40,566,901 | 10.51% | 0.02% |
| Jan. 4, 2024 | Sank Leonard | Director | A | Common Stock | 30000 | $0.00 | 88,696.0000 | 40,566,901 | 51.11% | 0.07% |
| Jan. 4, 2024 | Silberman David | Chief Financial Officer | A | Common Stock | 136500 | $0.00 | 366,500.0000 | 40,566,901 | 59.35% | 0.34% |
| Jan. 4, 2024 | Hexter Joshua | COO & CBO | A | Common Stock | 180500 | $0.00 | 481,833.0000 | 40,566,901 | 59.90% | 0.44% |